What is IPF Phase II FG-3019 Trial?

Category: Others

true

Generic name: FG-3019

The IPF Phase II FG-3019 is a randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of FG-3019 in patients with Idiopathic Pulmonary Fibrosis. NCT01890265

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
0
Mild
1
None
1

Commonly reported side effects and conditions associated with IPF Phase II FG-3019 Trial

Side effect Patients
Fatigue 1

Why patients stopped taking IPF Phase II FG-3019 Trial

Multiple reasons could be selected

Reason Patients
Other 1
See 1 patient who's stopped using IPF Phase II FG-3019 Trial

Duration

Stopped using IPF Phase II FG-3019 Trial

Duration Patients
2 - 5 years 1
Adherence
Adherence Evaluations
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 1
Last updated:
There are no evaluations for IPF Phase II FG-3019 Trial.